Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
March 13, 2024
Group sequential clinical trial designs — a type of adaptive clinical trial design — have emerged as a powerful tool in...
Read article
March 11, 2024
Quantitative Strategies for Rare Disease Clinical Trials
In 2023, rare diseases accounted for 30% of product pipeline under development, about half of which comprising...
Read article
May 16, 2022
Cytel & ARCS Collaborate to Strengthen Early Phase Capabilities
A combination of industry and policy forces have recently changed the shape of Australia’s R&D sector, making it a...
Read article
April 21, 2022
Bayesian Statistics and Its Applications: New Webinar by Professor Yuan Ji
Sophisticated Bayesian Methods are gaining a lot of traction as they bring flexibility and speed to clinical trial...
Read article
March 11, 2022
WINTER WEEKEND READ: Increased Adoption of Innovative Designs
Every year, sponsors hesitating to use a complex innovative clinical trial design routinely miss opportunities to...
Read article
February 2, 2021
Bayesian Methods for Master Protocols
As the use of master protocols becomes more prevalent in drug development, Bayesian methods are extensively used to...
Read article
October 12, 2020
Bayesian Statistics and FDA Regulatory Acceptability
Cytel and Novartis are together hosting a complimentary Bayesian Virtual Symposium and an Interactive 7-part workshop....
Read article